Factors associated with aggregate formation in cold‐stored platelets
Vox Sanguinis · 2026-08 · 121 (8) · 1181-1191
DOI: 10.1111/vox.70294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 24.05.2026. Verfasst von Samantha Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Bloodworks Northwest Research Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Blood Platelets, Blood Preservation, Platelet Aggregation, Cryopreservation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Defense.
Abstract (Originalsprache)
Background and Objectives Cold‐stored platelets (CSPs) can form aggregates, ultimately rendering them unusable. The causes of these aggregates and how to prevent them are poorly understood. This study aimed to identify potential factors associated with aggregate formation in CSPs stored in plasma for up to 14 days. Materials and Methods We obtained CSPs from 79 unique donors during a clinical trial. We retrospectively analysed aggregate rates among donors of different sexes, ages and blood groups. In a subgroup, samples were also tested by enzyme‐linked immunosorbent assay for markers of thrombosis and inflammation. Platelets from mice lacking von Willebrand factor (VWF) and human apheresis platelets treated with VWF and caplacizumab were stored and assessed for platelet count and aggregate formation by visual inspection and flow cytometry.
Results
Forty‐five (57%) units developed aggregates, and 34 (43%) did not. Units with aggregates had significantly lower soluble thrombomodulin levels and higher VWF levels approaching significance. In a multivariate analysis, platelets from female donors and donors with ABO type A were significantly more likely to form aggregates than those from male donors and donors with ABO type O, respectively. In the oldest donor cohort, units with aggregates were significantly less common than those without. Interfering with VWF levels and VWF function during storage did not reliably cause or prevent aggregates.
Conclusion
Donor sex, age, ABO type and thrombomodulin were significantly associated with aggregate formation or prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bloodworks Northwest Research Institute, Seattle, Washington, USA.
- Department of Manufacturing and Transfusion Services, South Texas Blood and Tissue Center, San Antonio, Texas, USA.
- Department of Blood Transfusion Service, Swedish Medical Center, Cherry Hill Campus, Seattle, Washington, USA.
- Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, USA.
- Department of Medical Services, Bloodworks Northwest, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Junmei Chen, Moritz Stolla
Förderung
- U.S. Department of Defense
Zitieren
APA
Huang, S., Mishima, Y., Bailey, S. L., Chauhan, A., Quesada, J., Klotz, P., Morrow, T., Provencher, K., Chen, J., López, J. A., Tsai, T. L., Panch, S., & Stolla, M. (2026). Factors associated with aggregate formation in cold‐stored platelets. Vox Sanguinis, 121(8), 1181-1191. https://doi.org/10.1111/vox.70294
Vancouver
Huang S, Mishima Y, Bailey SL, Chauhan A, Quesada J, Klotz P, et al. Factors associated with aggregate formation in cold‐stored platelets. Vox Sanguinis. 2026;121(8):1181-1191. doi:10.1111/vox.70294
BibTeX
@article{Huang2026,
author = {Huang, Samantha and Mishima, Yuko and Bailey, S Lawrence and Chauhan, Aastha and Quesada, José and Klotz, Pat and Morrow, Tyler and Provencher, Kathryn and Chen, Junmei and López, José A and Tsai, Tsung-Lin and Panch, Sandhya and Stolla, Moritz},
title = {Factors associated with aggregate formation in cold‐stored platelets},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {8},
pages = {1181--1191},
doi = {10.1111/vox.70294}
}
EUVIMED